Favaron, C.; Gaiaschi, L.; Casali, C.; De Luca, F.; Gola, F.; Cavallo, M.; Ramundo, V.; Aldieri, E.; Milanesi, G.; Visonà , S.D.;
et al. Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) Compound. Pharmaceutics 2024, 16, 1015.
https://doi.org/10.3390/pharmaceutics16081015
AMA Style
Favaron C, Gaiaschi L, Casali C, De Luca F, Gola F, Cavallo M, Ramundo V, Aldieri E, Milanesi G, Visonà SD,
et al. Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) Compound. Pharmaceutics. 2024; 16(8):1015.
https://doi.org/10.3390/pharmaceutics16081015
Chicago/Turabian Style
Favaron, Cristina, Ludovica Gaiaschi, Claudio Casali, Fabrizio De Luca, Federica Gola, Margherita Cavallo, Valeria Ramundo, Elisabetta Aldieri, Gloria Milanesi, Silvia Damiana Visonà ,
and et al. 2024. "Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) Compound" Pharmaceutics 16, no. 8: 1015.
https://doi.org/10.3390/pharmaceutics16081015
APA Style
Favaron, C., Gaiaschi, L., Casali, C., De Luca, F., Gola, F., Cavallo, M., Ramundo, V., Aldieri, E., Milanesi, G., Visonà , S. D., Ravera, M., & Bottone, M. G.
(2024). Unraveling Novel Strategies in Mesothelioma Treatments Using a Newly Synthetized Platinum(IV) Compound. Pharmaceutics, 16(8), 1015.
https://doi.org/10.3390/pharmaceutics16081015
